Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 15, 2010 - Issue 2
Submit an article Journal homepage
126
Views
2
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for chronic myeloid leukemia

Daniela Cilloni
, MD PhD,
Emanuela Messa University of Turin, Department of Clinical and Biological Sciences, S. Luigi Hospital, Regione Gonzole 10, 10043, Orbassano Turin, Italy +39 01 1670 5475; +39 01 1903 8636; [email protected]
, MD,
Antonia Rotolo University of Turin, Department of Clinical and Biological Sciences, S. Luigi Hospital, Regione Gonzole 10, 10043, Orbassano Turin, Italy +39 01 1670 5475; +39 01 1903 8636; [email protected]
, MD &
Giuseppe Saglio University of Turin, Department of Clinical and Biological Sciences, S. Luigi Hospital, Regione Gonzole 10, 10043, Orbassano Turin, Italy +39 01 1670 5475; +39 01 1903 8636; [email protected]
, MD
Pages 175-184 | Published online: 05 Mar 2010

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Bhupender S Chhikara & Keykavous Parang. (2010) Development of cytarabine prodrugs and delivery systems for leukemia treatment. Expert Opinion on Drug Delivery 7:12, pages 1399-1414.
Read now

Articles from other publishers (1)

Mio Yamamoto-SugitaniJunya KurodaEishi AshiharaHisao NagoshiTsutomu KobayashiYosuke MatsumotoNana SasakiYuji ShimuraMiki KiyotaRyuko NakayamaKenichi Akaji, Tomohiko TakiNobuhiko UoshimaYutaka Kobayashi, Shigeo HoriikeTaira Maekawa & Masafumi Taniwaki. (2011) Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia. Proceedings of the National Academy of Sciences 108:42, pages 17468-17473.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.